Literature DB >> 19917748

Anti-Clostridium difficile potential of tetramic acid derivatives from Pseudomonas aeruginosa quorum-sensing autoinducers.

Chihiro Ueda1, Kazuhiro Tateda, Manabu Horikawa, Soichiro Kimura, Yoshikazu Ishii, Kaoru Nomura, Kanako Yamada, Takashi Suematsu, Yasuhisa Inoue, Masaji Ishiguro, Shinichi Miyairi, Keizo Yamaguchi.   

Abstract

We have examined the potential bactericidal activities of several tetramic acids derived from Pseudomonas autoinducers against Clostridium difficile, a cause of antibiotic-associated pseudomembranous colitis. Clinical isolates of C. difficile (n=4) were incubated in broth with a chemically synthesized Pseudomonas autoinducer and its tetramic acid derivatives. The structure-activity relationship and the mechanisms of action were examined by a time-killing assay and by determination of the morphological/staining characteristics. The use of some tetramic acids derived from N-3-oxododecanoyl L-homoserine lactone resulted in more than 3-log reductions in the viability of C. difficile within 30 min at 30 microM. The outer membrane was suggested to be one of the targets for the bactericidal activity of tetramic acid, because disturbance of the bacterial outer surface was demonstrated by alteration of the Gram-staining characteristic and electron microscopy. The data for the tetramic acid derivatives demonstrate that the keto-enol structure and the length of the acyl side chain of tetramic acid may be essential for the antibacterial activity of this molecule. These results suggest the potential for tetramic acid derivatives to be novel agents with activity against C. difficile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917748      PMCID: PMC2812153          DOI: 10.1128/AAC.00702-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

2.  A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm.

Authors:  T S Charlton; R de Nys; A Netting; N Kumar; M Hentzer; M Givskov; S Kjelleberg
Journal:  Environ Microbiol       Date:  2000-10       Impact factor: 5.491

3.  Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584.

Authors:  M G Gänzle; A Höltzel; J Walter; G Jung; W P Hammes
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 4.  Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing.

Authors:  C Fuqua; M R Parsek; E P Greenberg
Journal:  Annu Rev Genet       Date:  2001       Impact factor: 16.830

5.  Bu-2313, a new antibiotic complex active against anaerobes. III. Semi-synthesis of Bu-2313 A and B, and their analogs.

Authors:  S Toda; S Nakagawa; T Naito; H Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1980-02       Impact factor: 2.649

6.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 7.  Clinical review of the management of fulminant clostridium difficile infection.

Authors:  M Raffat Jaber; Snorri Olafsson; Wesley L Fung; Mark E Reeves
Journal:  Am J Gastroenterol       Date:  2008-10-01       Impact factor: 10.864

Review 8.  Implications of the changing face of Clostridium difficile disease for health care practitioners.

Authors:  Lynne V McFarland; Henry W Beneda; Jill E Clarridge; Gregory J Raugi
Journal:  Am J Infect Control       Date:  2007-05       Impact factor: 2.918

Review 9.  Reutericyclin: biological activity, mode of action, and potential applications.

Authors:  M G Gänzle
Journal:  Appl Microbiol Biotechnol       Date:  2004-01-21       Impact factor: 4.813

10.  Microbial production of tenuazonic acid analogues.

Authors:  S Gatenbeck; J Sierankiewicz
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

View more
  7 in total

1.  Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

Authors:  Thomas P Wyche; René F Ramos Alvarenga; Jeff S Piotrowski; Megan N Duster; Simone R Warrack; Gabriel Cornilescu; Travis J De Wolfe; Yanpeng Hou; Doug R Braun; Gregory A Ellis; Scott W Simpkins; Justin Nelson; Chad L Myers; James Steele; Hirotada Mori; Nasia Safdar; John L Markley; Scott R Rajski; Tim S Bugni
Journal:  ACS Chem Biol       Date:  2017-07-26       Impact factor: 5.100

2.  Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.

Authors:  Philip T Cherian; Xiaoqian Wu; Lei Yang; Jerrod S Scarborough; Aman P Singh; Zahidul A Alam; Richard E Lee; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2015-08-18       Impact factor: 5.790

3.  Aldol reactions in multicomponent reaction based domino pathways: a multipurpose enabling tool in heterocyclic chemistry.

Authors:  Zhigang Xu; Fabio De Moliner; Alexandra P Cappelli; Christopher Hulme
Journal:  Org Lett       Date:  2013-05-29       Impact factor: 6.005

4.  5-Hydroxyethyl-3-tetradecanoyltetramic acid represents a novel treatment for intravascular catheter infections due to Staphylococcus aureus.

Authors:  Marta Zapotoczna; Ewan J Murray; Siobhan Hogan; James P O'Gara; Siri R Chhabra; Weng C Chan; Eoghan O'Neill; Paul Williams
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

5.  Antibacterial barbituric acid analogues inspired from natural 3-acyltetramic acids; synthesis, tautomerism and structure and physicochemical property-antibacterial activity relationships.

Authors:  Yong-Chul Jeong; Mark G Moloney
Journal:  Molecules       Date:  2015-02-20       Impact factor: 4.411

Review 6.  Clostridium difficile drug pipeline: challenges in discovery and development of new agents.

Authors:  Angie M Jarrad; Tomislav Karoli; Mark A T Blaskovich; Dena Lyras; Matthew A Cooper
Journal:  J Med Chem       Date:  2015-03-30       Impact factor: 7.446

7.  Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors.

Authors:  Ewan J Murray; Rebecca C Crowley; Alex Truman; Simon R Clarke; James A Cottam; Gopal P Jadhav; Victoria R Steele; Paul O'Shea; Catharina Lindholm; Alan Cockayne; Siri Ram Chhabra; Weng C Chan; Paul Williams
Journal:  J Med Chem       Date:  2014-03-13       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.